Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Moodys
AstraZeneca
Medtronic
Deloitte
Harvard Business School
Accenture
Chubb

Generated: June 25, 2018

DrugPatentWatch Database Preview

DOXY 200 Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Doxy 200, and what generic alternatives are available?

Doxy 200 is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in DOXY 200 is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety-nine suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for DOXY 200
Drug patent expirations by year for DOXY 200
Pharmacology for DOXY 200
Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug

US Patents and Regulatory Information for DOXY 200

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa DOXY 200 doxycycline hyclate INJECTABLE;INJECTION 062475-002 Dec 9, 1983 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Teva
Fish and Richardson
Express Scripts
Julphar
Fuji
Queensland Health
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.